Stay updated on Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial page.

Latest updates to the Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry (v3.4.2) appears in the history. The government funding operating-status notice that was previously displayed has been removed.SummaryDifference0.3%

- Check21 days agoChange DetectedThe page history now includes a new revision entry v3.4.1 and removes v3.4.0, and a site-wide notice about government funding is shown. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedThe Record History page now includes a glossary toggle and color-coded diffs (green for additions, red for deletions), and the revision label is updated to v3.4.0. The previous entry 'No FEAR Act Data' and the earlier 'Revision: v3.3.4' have been removed.SummaryDifference0.4%

- Check42 days agoChange DetectedThe record now shows the study is Completed as of 2026-01-07, with updated Study Design, Study Status, and Recruitment Status. The earlier Active, not recruiting status appears to have been superseded.SummaryDifference0.3%

- Check64 days agoChange DetectedThe page footer now shows Revision: v3.3.3, and references to HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision: v3.3.2 is now shown on the page history, replacing Revision: v3.3.1.SummaryDifference0.0%

Stay in the know with updates to Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Troriluzole Adjunct in OCD: Efficacy & Safety Clinical Trial page.